EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting

Zusammenhänge zwischen inflammatorischen Biomarkern und dem Schweregrad der COPD in einem Real-Life-Setting

Elena-Andreea Moaleș iD, Lucia Corina Dima-Cozma, Cristina Andreea Adam iD, Andrei Mihordea iD, Doina-Clementina Cojocaru iD, Paraschiva Postolache iD, Maura Gabriela Felea iD, Robert Negru, Ioana Mădălina Zota iD, Mitică Ciorpac iD, Romică Sebastian Cozma iD, Florin Dumitru Petrariu iD und 2 weitere

Journal of Clinical Medicine · 15.09.2025 · 14 (18) · 6481

DOI: 10.3390/jcm14186481 ↗

Auf einen Blick

Bei 100 Patient:innen mit stabiler COPD waren NLR und weitere Entzündungsmarker mit dem Schweregrad assoziiert. NLR zeigte eine gute Trennschärfe für GOLD 3–4 (AUC 0,66).

Fragestellung

Welche Rolle spielen inflammatorische Marker bei der Einschätzung des COPD-Schweregrads (GOLD 1 bis 4)?

Methode

Deskriptive Beobachtungsstudie mit Querschnittsdesign bei 100 Patient:innen mit stabiler COPD; klinische Untersuchung, Lungenfunktion und Entzündungs-Blutpanel.

Ergebnisse

55 Patient:innen mit GOLD 1–2, 33 mit GOLD 3 und 12 mit GOLD 4. Signifikant waren u. a. Geschlecht, Rauchen, BMI, IL-1 beta, NLR und nächtliche Herzfrequenz. NLR: AUC 0,66; Schwellenwert 2,3045.

Schlussfolgerung der Autor:innen

NLR erwies sich als einfacher, zugänglicher und informativer Biomarker bei COPD, verbunden mit Krankheitsgrad und funktionellem Abfall. Die Autor:innen sehen eine Bestätigung in multizentrischen Studien als nötig an.

Kernaussagen

  • NLR war mit der COPD-Schwere assoziiert.
  • NLR sagte GOLD 3–4 mit AUC 0,66 voraus.
  • Weitere Marker: IL-1 beta, IL-6, IL-8 und nächtliche Herzfrequenz.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.09.2025. Verfasst von Elena-Andreea Moaleș und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialities I, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Ia…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grigore T. Popa University of Medicine and Pharmacy, University of Medicine and Pharmacy “Grigore T. Popa”in Iași, Romania.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With a steady increase in prevalence, chronic obstructive pulmonary disease (COPD) is recognized as a leading contributor to global mortality, which underscores the need to identify prognostic biomarkers that are easy to use in everyday practice. As both local and systemic inflammation play a pivotal part in the development and progression of COPD, the purpose of our study was to assess the role of inflammatory markers in estimating disease severity (GOLD 1 to 4) to guide the management and treatment of patients with COPD, thus helping to reduce episodes of decompensation and fatal outcomes in both immediate and long-term contexts.

Methods

We performed a descriptive observational analysis with a cross-sectional design including 100 patients with stable COPD. All subjects underwent standard clinical examination, lung function tests and a comprehensive inflammation blood panel.

Results

We included 55 patients with mild–moderate COPD (GOLD 1–2), 33 patients with advanced stages of COPD (GOLD 3) and 12 patients with very severe forms of the disease (GOLD 4). Male sex, smoking status, BMI, IL-1 beta, NLR, and nocturnal heart rate were parameters with significant value for assessing COPD severity (p < 0.05 for all). NLR correlates significantly with the predicted distance in the 6 MWT (p = 0.039). Significant associations were identified between IL-8 and duration of exposure of biomass fuel (p = 0.045) as well as between IL-6 and pack-years (p = 0.024), with both prognostic and therapeutic impact. Furthermore, the analysis of the total cohort revealed positive correlations between serum IL-6 and FVC (%) (p = 0.033) or NLR and the ratio between FEV1 and FVC (p = 0.048). The neutrophil-to-lymphocyte ratio (NLR) proved to be a reliable indicator of stages 3–4 GOLD (AUC 0.66, threshold value 2.3045, p = 0.004—a one-point increase in NLR corresponded to a 2.148 increase in FEV1).

Conclusions

NLR emerged as a simple, accessible and highly informative biomarker in COPD, linked to disease severity and functional decline. Its integration into routine assessment could enhance prognosis and guide clinical decisions, a finding that warrants confirmation in future multicenter studies.

Schlagwörter

Stichwörter der Autor:innen

chronic obstructive pulmonary disease (COPD)inflammationinterleukin 1-beta (IL-1beta)interleukin 6 (IL-6)interleukin 8 (IL-8)lymphocyte/HDL-C ratio (LHR)neutrophil-to-lymphocyte ratio (NLR)platelet-to-lymphocyte ratio (PLR)tumor necrosis factor alpha (TNF-alpha)

Autor:innen und Institutionen

  • Department of Medical Specialities I, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Iași, Romania.
  • Elytis Hospital Iasi, Gheorghe Săulescu Street No. 43 A, 700010 Iasi, Romania.
  • Clinical Rehabilitation Hospital, Pantelimon Halipa Street No. 14, 700661 Iași, Romania.
  • Advanced Research and Development Center for Experimental Medicine "Prof. Ostin C. Mungiu"-CEMEX, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
  • 2nd Surgery Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No 16, 700115 Iași, Romania.
  • Department of Preventive Medicine and Interdisciplinarity, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Iași, Romania.

ORCID-Profile: Elena-Andreea Moaleș, Cristina Andreea Adam, Andrei Mihordea, Doina-Clementina Cojocaru, Paraschiva Postolache, Maura Gabriela Felea, Ioana Mădălina Zota, Mitică Ciorpac, Romică Sebastian Cozma, Florin Dumitru Petrariu, Maria Magdalena Leon, Florin Mitu

Förderung

  • Grigore T. Popa University of Medicine and Pharmacy
  • University of Medicine and Pharmacy “Grigore T. Popa”in Iași, Romania

Zitieren

APA

Moaleș, E. A., Dima-Cozma, L. C., Adam, C. A., Mihordea, A., Cojocaru, D. C., Postolache, P., Felea, M. G., Negru, R., Zota, I. M., Ciorpac, M., Cozma, R. S., Petrariu, F. D., Leon, M. M., & Mitu, F. (2025). Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting. Journal of Clinical Medicine, 14(18), 6481. https://doi.org/10.3390/jcm14186481

Vancouver

Moaleș EA, Dima-Cozma LC, Adam CA, Mihordea A, Cojocaru DC, Postolache P, et al. Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting. Journal of Clinical Medicine. 2025;14(18):6481. doi:10.3390/jcm14186481

BibTeX
@article{Moale2025,
  author = {Moaleș, Elena-Andreea and Dima-Cozma, Lucia Corina and Adam, Cristina Andreea and Mihordea, Andrei and Cojocaru, Doina-Clementina and Postolache, Paraschiva and Felea, Maura Gabriela and Negru, Robert and Zota, Ioana Mădălina and Ciorpac, Mitică and Cozma, Romică Sebastian and Petrariu, Florin Dumitru and Leon, Maria Magdalena and Mitu, Florin},
  title = {Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {18},
  pages = {6481},
  doi = {10.3390/jcm14186481}
}
Kostenlos starten →